Trend analysis Archives - Page 2 of 3

What are the recent trends in nutraceutical products for sleep?

Recent trends in sleep supplements

April 13, 2024/in Sleep Trend analysis Article/by Matevž Ambrožič

Sleep quality emerges as the main driver of demand and new product development.

Nutraceutical products based on nootropic ingredients are on the rise.

The rise of nootropics

March 30, 2024/in Cognition, Nootropics Trend analysis Article/by Matevž Ambrožič

As cognitive performance becomes more important, nutraceutical products based on nootropic ingredients are on the rise.

Liquids, sprays, shots, and gummies are gaining popularity in nutraceutical products.

Recent trends in galenics in Europe

March 30, 2024/in Delivery formats Trend analysis Article/by Matevž Ambrožič

Among delivery formats in European food supplements, liquids, such as sprays and shots, and gummies are gaining popularity.

Doctor-driven influencer marketing

March 28, 2024/in Clinical research, Urinary tract, Women's health Trend analysis Webinar/by Kaja Steblovnik

How do credible nutraceutical brands use influencers to boost awareness, trust, and sales? Find out in a webinar by PharmaLinea and Epidemic, an industry-leading influencer marketing agency.

Spotlight on the recent nutraceutical product launches

Nutraceuticals as a revenue opportunity for pharma

March 15, 2024/in Blood glucose, Clinical research, Pain, Pharma/nutra convergence, Women's health Trend analysis PDF/by Matevž Ambrožič

At PharmaSynergy 2023 and Nicholas Hall 33rd European CHC Conference 2023, we discussed how nutraceuticals can present a new revenue opportunity for pharma companies.

Nutraceutical trends talk with Kenn Israel

February 2, 2024/in Adaptogens, Clinical research, Delivery formats, Digital health, Pain, Women's health Trend analysis Podcast/by Matevž Ambrožič

We discussed upcoming indications, delivery formats, and other trends in the nutraceutical industry with Kenn Israel of Innovation Nutrition Consulting LLC.

Nutraceutical market trends for 2024

January 5, 2024/in Blood glucose, Clinical research, Cognition, Delivery formats, Digital health, Healthy aging, Hydration, Marketing campaigns, Pain, Pharma/nutra convergence, Urinary tract, Women's health Trend analysis Webinar/by Kaja Steblovnik

PharmaLinea once again partnered with IQVIA to deliver a webinar on nutraceutical product market trends for 2024.

Spotlight on recent nutraceutical product launches

January 4, 2024/in Clinical research, Pain, Pharma/nutra convergence Trend analysis PDF/by Kaja Steblovnik

How are worldwide leaders, such as STADA, Haleon, or GNC addressing current nutraceutical trends with their recent product launches?

French market opportunities for women and children’s supplements

November 23, 2023/in Children's health, Clinical research, Women's health Trend analysis Webinar/by Kaja Steblovnik

PharmaLinea and OpenHealth discussed the trends and opportunities for women and children’s supplements in the French market.

5 best marketing practices in 2023

September 21, 2023/in Clinical research, Pain, Pharma/nutra convergence Trend analysis PDF/by Kaja Steblovnik

We prepared a collection of the best marketing campaigns from our clients, our clinical trial recruitment, and various OTC consumer healthcare brands.

WHY OUR PRODUCTS

WHY OUR SERVICE

Scientific Consultancy

By Indication

By Demography

By Form

The contents of this website do not provide medical advice, diagnosis, or treatment, and the information included on the website is offered for informational purposes only. As a result, you should never use the information you obtain on the website for diagnosis or treatment of any health problem or in place of any medication or other treatment prescribed by a physician or other healthcare provider.
Please consult with your physician or other healthcare provider if you have health-related questions before using any of products or relying on any information you obtain on the website. You should discuss any medications or nutritional supplements you are using with a healthcare provider before using any new medications or supplements. These statements have not been evaluated by any local Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease.